XML 107 R93.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment reporting information        
Revenues $ 2,510,000,000 $ 2,238,000,000 $ 7,066,000,000 $ 6,349,000,000
Operating income 318,000,000 14,000,000 988,000,000 601,000,000
Amortization of intangible assets (274,000,000) (253,000,000) (818,000,000) (795,000,000)
Goodwill impairments 0 (402,000,000) 0 (402,000,000)
Asset impairments 0 (4,000,000) (6,000,000) (54,000,000)
Restructuring, integration and separation costs (1,000,000) (14,000,000) (25,000,000) (40,000,000)
Other expense, net (225,000,000) (60,000,000) (245,000,000) 0
Interest income 7,000,000 6,000,000 24,000,000 19,000,000
Interest expense (346,000,000) (339,000,000) (1,051,000,000) (965,000,000)
Gain on extinguishment of debt 0 0 23,000,000 0
Foreign exchange and other 0 (7,000,000) (26,000,000) (38,000,000)
Loss before income taxes (21,000,000) (326,000,000) (42,000,000) (383,000,000)
Salix        
Segment reporting information        
Revenues 642,000,000 614,000,000 1,699,000,000 1,667,000,000
International        
Segment reporting information        
Revenues 291,000,000 275,000,000 832,000,000 781,000,000
Solta Medical        
Segment reporting information        
Revenues 112,000,000 83,000,000 302,000,000 244,000,000
Diversified        
Segment reporting information        
Revenues 269,000,000 259,000,000 722,000,000 684,000,000
Bausch + Lomb        
Segment reporting information        
Revenues 1,196,000,000 1,007,000,000 3,511,000,000 2,973,000,000
Operating Segment        
Segment reporting information        
Revenues 2,510,000,000 2,238,000,000 7,066,000,000 6,349,000,000
Operating income 1,066,000,000 969,000,000 2,828,000,000 2,595,000,000
Operating Segment | Salix        
Segment reporting information        
Revenues 642,000,000 614,000,000 1,699,000,000 1,667,000,000
Operating income 436,000,000 429,000,000 1,142,000,000 1,129,000,000
Operating Segment | International        
Segment reporting information        
Revenues 291,000,000 275,000,000 832,000,000 781,000,000
Operating income 105,000,000 91,000,000 278,000,000 236,000,000
Operating Segment | Solta Medical        
Segment reporting information        
Revenues 112,000,000 83,000,000 302,000,000 244,000,000
Operating income 53,000,000 33,000,000 140,000,000 114,000,000
Operating Segment | Diversified        
Segment reporting information        
Revenues 269,000,000 259,000,000 722,000,000 684,000,000
Operating income 189,000,000 172,000,000 469,000,000 417,000,000
Operating Segment | Bausch + Lomb        
Segment reporting information        
Revenues 1,196,000,000 1,007,000,000 3,511,000,000 2,973,000,000
Operating income 283,000,000 244,000,000 799,000,000 699,000,000
Corporate        
Segment reporting information        
Operating income $ (248,000,000) $ (222,000,000) $ (746,000,000) $ (703,000,000)